P2 data • Preclinical • CAR T-Cell Therapy
|
CD8 (cluster of differentiation 8)
|
LDH elevation • CD19 positive
|
cyclophosphamide • Yescarta (axicabtagene ciloleucel) • Breyanzi (lisocabtagene maraleucel) • Kymriah (tisagenlecleucel-T) • fludarabine IV